Zhang, Y., Jia, Q., Kadel, D., Zhang, X., & Zhang, Q. (2018). Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC). Med Sci Monit.
Citação norma ChicagoZhang, Yu, Qing-an Jia, Dhruba Kadel, Xiao-fei Zhang, and Quan-bao Zhang. "Targeting MTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of MTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)." Med Sci Monit 2018.
Citação norma MLAZhang, Yu, et al. "Targeting MTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of MTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC)." Med Sci Monit 2018.